| ABO |
P16442
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
|
Enzyme
|
|
0.427 |
0.885 |
| ADH1C |
P00326
|
alcohol dehydrogenase 1C (class I), gamma polypeptide
|
Enzyme
|
|
0.547 |
0.731 |
| ATD |
|
asphixiating thoracic dystrophy (chondroectodermal dysplasia-like syndrome)
|
|
|
0.656 |
0.731 |
| ATHS |
|
atherosclerosis susceptibility (lipoprotein associated)
|
|
|
0.551 |
0.769 |
| BAGE |
Q13072
|
B melanoma antigen
|
|
|
0.711 |
0.346 |
| CMD1B |
|
cardiomyopathy, dilated 1B (autosomal dominant)
|
|
|
0.722 |
0.500 |
| IFNA1 |
P01562
|
interferon alpha 1
|
|
|
0.371 |
0.923 |
| IFNA2 |
P01563
|
interferon alpha 2
|
|
|
0.442 |
0.885 |
| IFNA13 |
P01562
|
interferon alpha 13
|
|
|
0.374 |
0.923 |
| KIR2DS4 |
P43632
|
killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 4
|
Receptor
|
|
0.674 |
0.500 |
| COX2 |
P00403
|
cytochrome c oxidase subunit II
|
Enzyme
|
|
0.352 |
0.962 |
| NM |
|
neutrophil migration
|
|
|
0.473 |
0.808 |
| OATP1 |
|
ornithine aminotransferase pseudogene 1
|
|
|
0.890 |
0.154 |
| PECAM1 |
P16284
|
platelet and endothelial cell adhesion molecule 1
|
Cell adhesion
|
|
0.426 |
0.846 |
| TDGF1P3 |
P51864
|
teratocarcinoma-derived growth factor 1 pseudogene 3
|
Calcium-binding protein
|
|
0.631 |
0.500 |
| TERC |
|
telomerase RNA component
|
|
|
0.471 |
0.846 |
| DLEU2 |
|
deleted in lymphocytic leukemia 2
|
|
|
0.650 |
0.500 |
| NANS |
Q9NR45
|
N-acetylneuraminate synthase
|
Enzyme
|
|
0.545 |
0.692 |
| GER |
|
Gastroesophageal reflux
|
|
|
0.678 |
0.538 |
| FRTS1 |
|
Fanconi renotubular syndrome
|
|
|
0.599 |
0.654 |
| FOXD2-AS1 |
|
FOXD2 adjacent opposite strand RNA 1
|
|
|
0.644 |
0.423 |
| GRDX |
|
Graves disease, susceptibility to, X-linked
|
|
|
0.839 |
0.231 |
| CKS1BP7 |
|
CDC28 protein kinase regulatory subunit 1B pseudogene 7
|
|
|
0.610 |
0.577 |
| FOLH1B |
Q9HBA9
|
folate hydrolase 1B
|
Enzyme
|
|
0.682 |
0.538 |
| COPD |
|
Pulmonary disease, chronic obstructive, severe early-onset
|
|
|
0.456 |
0.885 |